Contact this trialFirst, we need to learn more about you.
Immunotherapy
AGEN1423 + Balstilimab With/Without Chemo for Pancreatic Cancer
Recruiting1 awardPhase 2
Boston, Massachusetts
This trial is testing new drugs AGEN1423 and Balstilimab, alone or with chemotherapy, for advanced pancreatic cancer patients who didn't respond to previous treatments. The treatment aims to boost the immune system to fight cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service